Personalized Medicine-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Personalized Medicine-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Personalized Medicine industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Personalized Medicine 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Personalized Medicine worldwide and market share by regions, with company and product introduction, position in the Personalized Medicine market
Market status and development trend of Personalized Medicine by types and applications
Cost and profit status of Personalized Medicine, and marketing status
Market growth drivers and challenges
The report segments the global Personalized Medicine market as:
Global Personalized Medicine Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Personalized Medicine Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Diagnostic
Therapeutics
Medical Care
Nutrition
Wellness
Global Personalized Medicine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Molecular Diagnostic Laboratories and Testing Centers
Academic Institutes
Bio and Health Informatics Companies
Others
Global Personalized Medicine Market: Manufacturers Segment Analysis (Company and Product introduction, Personalized Medicine Sales Volume, Revenue, Price and Gross Margin):
Laboratory Corporation of America
Quest Diagnostics
Abbott, Becton Dickinson & Co
Siemens Healthcare Diagnostics Inc
GE Healthcare
Pfizer Inc
Sanofi
CardioDx
Asuragen Inc
Bristol-Myers Squibb
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Personalized Medicine-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Personalized Medicine industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Personalized Medicine 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Personalized Medicine worldwide and market share by regions, with company and product introduction, position in the Personalized Medicine market
Market status and development trend of Personalized Medicine by types and applications
Cost and profit status of Personalized Medicine, and marketing status
Market growth drivers and challenges
The report segments the global Personalized Medicine market as:
Global Personalized Medicine Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Personalized Medicine Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Diagnostic
Therapeutics
Medical Care
Nutrition
Wellness
Global Personalized Medicine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Molecular Diagnostic Laboratories and Testing Centers
Academic Institutes
Bio and Health Informatics Companies
Others
Global Personalized Medicine Market: Manufacturers Segment Analysis (Company and Product introduction, Personalized Medicine Sales Volume, Revenue, Price and Gross Margin):
Laboratory Corporation of America
Quest Diagnostics
Abbott, Becton Dickinson & Co
Siemens Healthcare Diagnostics Inc
GE Healthcare
Pfizer Inc
Sanofi
CardioDx
Asuragen Inc
Bristol-Myers Squibb
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PERSONALIZED MEDICINE
1.1 Definition of Personalized Medicine in This Report
1.2 Commercial Types of Personalized Medicine
1.2.1 Diagnostic
1.2.2 Therapeutics
1.2.3 Medical Care
1.2.4 Nutrition
1.2.5 Wellness
1.3 Downstream Application of Personalized Medicine
1.3.1 Hospitals
1.3.2 Molecular Diagnostic Laboratories and Testing Centers
1.3.3 Academic Institutes
1.3.4 Bio and Health Informatics Companies
1.3.5 Others
1.4 Development History of Personalized Medicine
1.5 Market Status and Trend of Personalized Medicine 2013-2023
1.5.1 Global Personalized Medicine Market Status and Trend 2013-2023
1.5.2 Regional Personalized Medicine Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Personalized Medicine 2013-2017
2.2 Sales Market of Personalized Medicine by Regions
2.2.1 Sales Volume of Personalized Medicine by Regions
2.2.2 Sales Value of Personalized Medicine by Regions
2.3 Production Market of Personalized Medicine by Regions
2.4 Global Market Forecast of Personalized Medicine 2018-2023
2.4.1 Global Market Forecast of Personalized Medicine 2018-2023
2.4.2 Market Forecast of Personalized Medicine by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Personalized Medicine by Types
3.2 Sales Value of Personalized Medicine by Types
3.3 Market Forecast of Personalized Medicine by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Personalized Medicine by Downstream Industry
4.2 Global Market Forecast of Personalized Medicine by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Personalized Medicine Market Status by Countries
5.1.1 North America Personalized Medicine Sales by Countries (2013-2017)
5.1.2 North America Personalized Medicine Revenue by Countries (2013-2017)
5.1.3 United States Personalized Medicine Market Status (2013-2017)
5.1.4 Canada Personalized Medicine Market Status (2013-2017)
5.1.5 Mexico Personalized Medicine Market Status (2013-2017)
5.2 North America Personalized Medicine Market Status by Manufacturers
5.3 North America Personalized Medicine Market Status by Type (2013-2017)
5.3.1 North America Personalized Medicine Sales by Type (2013-2017)
5.3.2 North America Personalized Medicine Revenue by Type (2013-2017)
5.4 North America Personalized Medicine Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Personalized Medicine Market Status by Countries
6.1.1 Europe Personalized Medicine Sales by Countries (2013-2017)
6.1.2 Europe Personalized Medicine Revenue by Countries (2013-2017)
6.1.3 Germany Personalized Medicine Market Status (2013-2017)
6.1.4 UK Personalized Medicine Market Status (2013-2017)
6.1.5 France Personalized Medicine Market Status (2013-2017)
6.1.6 Italy Personalized Medicine Market Status (2013-2017)
6.1.7 Russia Personalized Medicine Market Status (2013-2017)
6.1.8 Spain Personalized Medicine Market Status (2013-2017)
6.1.9 Benelux Personalized Medicine Market Status (2013-2017)
6.2 Europe Personalized Medicine Market Status by Manufacturers
6.3 Europe Personalized Medicine Market Status by Type (2013-2017)
6.3.1 Europe Personalized Medicine Sales by Type (2013-2017)
6.3.2 Europe Personalized Medicine Revenue by Type (2013-2017)
6.4 Europe Personalized Medicine Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Personalized Medicine Market Status by Countries
7.1.1 Asia Pacific Personalized Medicine Sales by Countries (2013-2017)
7.1.2 Asia Pacific Personalized Medicine Revenue by Countries (2013-2017)
7.1.3 China Personalized Medicine Market Status (2013-2017)
7.1.4 Japan Personalized Medicine Market Status (2013-2017)
7.1.5 India Personalized Medicine Market Status (2013-2017)
7.1.6 Southeast Asia Personalized Medicine Market Status (2013-2017)
7.1.7 Australia Personalized Medicine Market Status (2013-2017)
7.2 Asia Pacific Personalized Medicine Market Status by Manufacturers
7.3 Asia Pacific Personalized Medicine Market Status by Type (2013-2017)
7.3.1 Asia Pacific Personalized Medicine Sales by Type (2013-2017)
7.3.2 Asia Pacific Personalized Medicine Revenue by Type (2013-2017)
7.4 Asia Pacific Personalized Medicine Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Personalized Medicine Market Status by Countries
8.1.1 Latin America Personalized Medicine Sales by Countries (2013-2017)
8.1.2 Latin America Personalized Medicine Revenue by Countries (2013-2017)
8.1.3 Brazil Personalized Medicine Market Status (2013-2017)
8.1.4 Argentina Personalized Medicine Market Status (2013-2017)
8.1.5 Colombia Personalized Medicine Market Status (2013-2017)
8.2 Latin America Personalized Medicine Market Status by Manufacturers
8.3 Latin America Personalized Medicine Market Status by Type (2013-2017)
8.3.1 Latin America Personalized Medicine Sales by Type (2013-2017)
8.3.2 Latin America Personalized Medicine Revenue by Type (2013-2017)
8.4 Latin America Personalized Medicine Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Personalized Medicine Market Status by Countries
9.1.1 Middle East and Africa Personalized Medicine Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Personalized Medicine Revenue by Countries (2013-2017)
9.1.3 Middle East Personalized Medicine Market Status (2013-2017)
9.1.4 Africa Personalized Medicine Market Status (2013-2017)
9.2 Middle East and Africa Personalized Medicine Market Status by Manufacturers
9.3 Middle East and Africa Personalized Medicine Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Personalized Medicine Sales by Type (2013-2017)
9.3.2 Middle East and Africa Personalized Medicine Revenue by Type (2013-2017)
9.4 Middle East and Africa Personalized Medicine Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF PERSONALIZED MEDICINE
10.1 Global Economy Situation and Trend Overview
10.2 Personalized Medicine Downstream Industry Situation and Trend Overview
CHAPTER 11 PERSONALIZED MEDICINE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Personalized Medicine by Major Manufacturers
11.2 Production Value of Personalized Medicine by Major Manufacturers
11.3 Basic Information of Personalized Medicine by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Personalized Medicine Major Manufacturer
11.3.2 Employees and Revenue Level of Personalized Medicine Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 PERSONALIZED MEDICINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Laboratory Corporation of America
12.1.1 Company profile
12.1.2 Representative Personalized Medicine Product
12.1.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Laboratory Corporation of America
12.2 Quest Diagnostics
12.2.1 Company profile
12.2.2 Representative Personalized Medicine Product
12.2.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Quest Diagnostics
12.3 Abbott, Becton Dickinson & Co
12.3.1 Company profile
12.3.2 Representative Personalized Medicine Product
12.3.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Abbott, Becton Dickinson & Co
12.4 Siemens Healthcare Diagnostics Inc
12.4.1 Company profile
12.4.2 Representative Personalized Medicine Product
12.4.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Siemens Healthcare Diagnostics Inc
12.5 GE Healthcare
12.5.1 Company profile
12.5.2 Representative Personalized Medicine Product
12.5.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of GE Healthcare
12.6 Pfizer Inc
12.6.1 Company profile
12.6.2 Representative Personalized Medicine Product
12.6.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Pfizer Inc
12.7 Sanofi
12.7.1 Company profile
12.7.2 Representative Personalized Medicine Product
12.7.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Sanofi
12.8 CardioDx
12.8.1 Company profile
12.8.2 Representative Personalized Medicine Product
12.8.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of CardioDx
12.9 Asuragen Inc
12.9.1 Company profile
12.9.2 Representative Personalized Medicine Product
12.9.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Asuragen Inc
12.10 Bristol-Myers Squibb
12.10.1 Company profile
12.10.2 Representative Personalized Medicine Product
12.10.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PERSONALIZED MEDICINE
13.1 Industry Chain of Personalized Medicine
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF PERSONALIZED MEDICINE
14.1 Cost Structure Analysis of Personalized Medicine
14.2 Raw Materials Cost Analysis of Personalized Medicine
14.3 Labor Cost Analysis of Personalized Medicine
14.4 Manufacturing Expenses Analysis of Personalized Medicine
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Personalized Medicine in This Report
1.2 Commercial Types of Personalized Medicine
1.2.1 Diagnostic
1.2.2 Therapeutics
1.2.3 Medical Care
1.2.4 Nutrition
1.2.5 Wellness
1.3 Downstream Application of Personalized Medicine
1.3.1 Hospitals
1.3.2 Molecular Diagnostic Laboratories and Testing Centers
1.3.3 Academic Institutes
1.3.4 Bio and Health Informatics Companies
1.3.5 Others
1.4 Development History of Personalized Medicine
1.5 Market Status and Trend of Personalized Medicine 2013-2023
1.5.1 Global Personalized Medicine Market Status and Trend 2013-2023
1.5.2 Regional Personalized Medicine Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Personalized Medicine 2013-2017
2.2 Sales Market of Personalized Medicine by Regions
2.2.1 Sales Volume of Personalized Medicine by Regions
2.2.2 Sales Value of Personalized Medicine by Regions
2.3 Production Market of Personalized Medicine by Regions
2.4 Global Market Forecast of Personalized Medicine 2018-2023
2.4.1 Global Market Forecast of Personalized Medicine 2018-2023
2.4.2 Market Forecast of Personalized Medicine by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Personalized Medicine by Types
3.2 Sales Value of Personalized Medicine by Types
3.3 Market Forecast of Personalized Medicine by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Personalized Medicine by Downstream Industry
4.2 Global Market Forecast of Personalized Medicine by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Personalized Medicine Market Status by Countries
5.1.1 North America Personalized Medicine Sales by Countries (2013-2017)
5.1.2 North America Personalized Medicine Revenue by Countries (2013-2017)
5.1.3 United States Personalized Medicine Market Status (2013-2017)
5.1.4 Canada Personalized Medicine Market Status (2013-2017)
5.1.5 Mexico Personalized Medicine Market Status (2013-2017)
5.2 North America Personalized Medicine Market Status by Manufacturers
5.3 North America Personalized Medicine Market Status by Type (2013-2017)
5.3.1 North America Personalized Medicine Sales by Type (2013-2017)
5.3.2 North America Personalized Medicine Revenue by Type (2013-2017)
5.4 North America Personalized Medicine Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Personalized Medicine Market Status by Countries
6.1.1 Europe Personalized Medicine Sales by Countries (2013-2017)
6.1.2 Europe Personalized Medicine Revenue by Countries (2013-2017)
6.1.3 Germany Personalized Medicine Market Status (2013-2017)
6.1.4 UK Personalized Medicine Market Status (2013-2017)
6.1.5 France Personalized Medicine Market Status (2013-2017)
6.1.6 Italy Personalized Medicine Market Status (2013-2017)
6.1.7 Russia Personalized Medicine Market Status (2013-2017)
6.1.8 Spain Personalized Medicine Market Status (2013-2017)
6.1.9 Benelux Personalized Medicine Market Status (2013-2017)
6.2 Europe Personalized Medicine Market Status by Manufacturers
6.3 Europe Personalized Medicine Market Status by Type (2013-2017)
6.3.1 Europe Personalized Medicine Sales by Type (2013-2017)
6.3.2 Europe Personalized Medicine Revenue by Type (2013-2017)
6.4 Europe Personalized Medicine Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Personalized Medicine Market Status by Countries
7.1.1 Asia Pacific Personalized Medicine Sales by Countries (2013-2017)
7.1.2 Asia Pacific Personalized Medicine Revenue by Countries (2013-2017)
7.1.3 China Personalized Medicine Market Status (2013-2017)
7.1.4 Japan Personalized Medicine Market Status (2013-2017)
7.1.5 India Personalized Medicine Market Status (2013-2017)
7.1.6 Southeast Asia Personalized Medicine Market Status (2013-2017)
7.1.7 Australia Personalized Medicine Market Status (2013-2017)
7.2 Asia Pacific Personalized Medicine Market Status by Manufacturers
7.3 Asia Pacific Personalized Medicine Market Status by Type (2013-2017)
7.3.1 Asia Pacific Personalized Medicine Sales by Type (2013-2017)
7.3.2 Asia Pacific Personalized Medicine Revenue by Type (2013-2017)
7.4 Asia Pacific Personalized Medicine Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Personalized Medicine Market Status by Countries
8.1.1 Latin America Personalized Medicine Sales by Countries (2013-2017)
8.1.2 Latin America Personalized Medicine Revenue by Countries (2013-2017)
8.1.3 Brazil Personalized Medicine Market Status (2013-2017)
8.1.4 Argentina Personalized Medicine Market Status (2013-2017)
8.1.5 Colombia Personalized Medicine Market Status (2013-2017)
8.2 Latin America Personalized Medicine Market Status by Manufacturers
8.3 Latin America Personalized Medicine Market Status by Type (2013-2017)
8.3.1 Latin America Personalized Medicine Sales by Type (2013-2017)
8.3.2 Latin America Personalized Medicine Revenue by Type (2013-2017)
8.4 Latin America Personalized Medicine Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Personalized Medicine Market Status by Countries
9.1.1 Middle East and Africa Personalized Medicine Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Personalized Medicine Revenue by Countries (2013-2017)
9.1.3 Middle East Personalized Medicine Market Status (2013-2017)
9.1.4 Africa Personalized Medicine Market Status (2013-2017)
9.2 Middle East and Africa Personalized Medicine Market Status by Manufacturers
9.3 Middle East and Africa Personalized Medicine Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Personalized Medicine Sales by Type (2013-2017)
9.3.2 Middle East and Africa Personalized Medicine Revenue by Type (2013-2017)
9.4 Middle East and Africa Personalized Medicine Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF PERSONALIZED MEDICINE
10.1 Global Economy Situation and Trend Overview
10.2 Personalized Medicine Downstream Industry Situation and Trend Overview
CHAPTER 11 PERSONALIZED MEDICINE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Personalized Medicine by Major Manufacturers
11.2 Production Value of Personalized Medicine by Major Manufacturers
11.3 Basic Information of Personalized Medicine by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Personalized Medicine Major Manufacturer
11.3.2 Employees and Revenue Level of Personalized Medicine Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 PERSONALIZED MEDICINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Laboratory Corporation of America
12.1.1 Company profile
12.1.2 Representative Personalized Medicine Product
12.1.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Laboratory Corporation of America
12.2 Quest Diagnostics
12.2.1 Company profile
12.2.2 Representative Personalized Medicine Product
12.2.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Quest Diagnostics
12.3 Abbott, Becton Dickinson & Co
12.3.1 Company profile
12.3.2 Representative Personalized Medicine Product
12.3.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Abbott, Becton Dickinson & Co
12.4 Siemens Healthcare Diagnostics Inc
12.4.1 Company profile
12.4.2 Representative Personalized Medicine Product
12.4.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Siemens Healthcare Diagnostics Inc
12.5 GE Healthcare
12.5.1 Company profile
12.5.2 Representative Personalized Medicine Product
12.5.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of GE Healthcare
12.6 Pfizer Inc
12.6.1 Company profile
12.6.2 Representative Personalized Medicine Product
12.6.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Pfizer Inc
12.7 Sanofi
12.7.1 Company profile
12.7.2 Representative Personalized Medicine Product
12.7.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Sanofi
12.8 CardioDx
12.8.1 Company profile
12.8.2 Representative Personalized Medicine Product
12.8.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of CardioDx
12.9 Asuragen Inc
12.9.1 Company profile
12.9.2 Representative Personalized Medicine Product
12.9.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Asuragen Inc
12.10 Bristol-Myers Squibb
12.10.1 Company profile
12.10.2 Representative Personalized Medicine Product
12.10.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PERSONALIZED MEDICINE
13.1 Industry Chain of Personalized Medicine
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF PERSONALIZED MEDICINE
14.1 Cost Structure Analysis of Personalized Medicine
14.2 Raw Materials Cost Analysis of Personalized Medicine
14.3 Labor Cost Analysis of Personalized Medicine
14.4 Manufacturing Expenses Analysis of Personalized Medicine
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
